NEWLY DIAGNOSED MULTIPLE MYELOMA ELDERLY PATIENTS
Chairmen: Hirokazu Murakami, Paul G. Richardson
Debate - Change Therapy for High/Low Risk Patients - Yes
S. Vincent Rajkumar
SLIDES |
Debate - Change Therapy for High/Low Risk Patients - No
Paul G. Richardson
Conclusions:
- Apply the best possible treatment at all stages and across the patient spectrum
- Incorporate novel agents as combinations
- Challenge clonal heterogeneity and improve outcome
- Enrol in clinical trials
SLIDES |
Optimal Therapy for Fit Elderly Patients
Ruben Niesvizky
The older fit patient, therapeutic considerations:
Is CR/MRD the goal? YES
Is transplant therapy the way? CAN BE
Is continued treatment best? YES
Can novel drugs improve outcome? YES
SLIDES |
Optimal Therapy for Unfit Elderly Patients
Sonja Zweegman
SLIDES |